Nifty

:

25285.35

Sensex

:

82500.82

103.55 (0.41%)
328.72 (0.40%)

Login

Nifty
Sensex

:
:

25285.35
82500.82

103.55 (0.41%)
328.72 (0.40%)

Sanjivani Paranteral Ltd.

Pharmaceuticals & Drugs

Rating :

52/99

BSE: 531569 | NSE: Not Listed

Watchlist

NSE BSE

214.85

10-Oct-2025

Open
High
Low
Previous Close

216
217
210
210.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

3014
642048
217
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

263.93
31.83
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

267.99
N/A
N/A

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-8.55
27.17
21.14

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.18
-
13.51

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
8.35

P:E (Median)

8 Years
5 Years
3 Years

11.92
18.37
32.74

P:BV (Average)

8 Years
5 Years
3 Years

49.63
52.27
77.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

1.40
22.04
22.13

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 17.89 16.44 8.82% 18.18 12.86 41.37% 17.35 14.96 15.98% 18.13 14.00 29.50%
Expenses 15.25 14.10 8.16% 15.56 10.71 45.28% 14.80 13.00 13.85% 15.28 11.89 28.51%
EBITDA 2.65 2.34 13.25% 2.62 2.16 21.30% 2.55 1.96 30.10% 2.85 2.11 35.07%
EBIDTM 14.79% 14.22% 14.41% 16.78% 14.70% 13.09% 15.74% 15.10%
Other Income 0.04 0.09 -55.56% 0.43 0.05 760.00% 0.31 0.25 24.00% 0.39 0.15 160.00%
Interest 0.22 0.02 1,000.00% 0.20 0.09 122.22% 0.19 0.08 137.50% 0.18 0.05 260.00%
Depreciation 0.16 0.13 23.08% 0.18 0.24 -25.00% 0.16 0.24 -33.33% 0.15 0.23 -34.78%
PBT 2.30 2.27 1.32% 2.66 1.89 40.74% 2.51 1.90 32.11% 2.92 1.99 46.73%
Tax 0.57 0.56 1.79% 0.47 0.63 -25.40% 0.61 0.25 144.00% 0.62 0.28 121.43%
PAT 1.73 1.71 1.17% 2.19 1.26 73.81% 1.90 1.65 15.15% 2.30 1.71 34.50%
PATM 9.66% 10.43% 12.06% 9.78% 10.94% 11.03% 12.66% 12.18%
EPS 1.45 1.44 0.69% 1.84 1.06 73.58% 1.59 1.39 14.39% 1.93 1.43 34.97%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 17.89 0.00 0 18.18 0.00 0 17.35 0.00 0 18.13 0.00 0
Expenses 15.25 0.00 0 15.57 0.00 0 14.80 0.00 0 15.28 0.00 0
EBITDA 2.65 0.00 0 2.61 0.00 0 2.55 0.00 0 2.85 0.00 0
EBIDTM 14.79% 0.00% 14.37% 0.00% 14.70% 0.00% 15.74% 0.00%
Other Income 0.04 0.00 0 0.43 0.00 0 0.31 0.00 0 0.39 0.00 0
Interest 0.22 0.00 0 0.20 0.00 0 0.19 0.00 0 0.18 0.00 0
Depreciation 0.16 0.00 0 0.18 0.00 0 0.16 0.00 0 0.15 0.00 0
PBT 2.30 0.00 0 2.65 0.00 0 2.51 0.00 0 2.92 0.00 0
Tax 0.57 0.00 0 0.47 0.00 0 0.61 0.00 0 0.62 0.00 0
PAT 1.73 0.00 0 2.19 0.00 0 1.90 0.00 0 2.30 0.00 0
PATM 9.66% 0.00% 12.02% 0.00% 10.94% 0.00% 12.66% 0.00%
EPS 1.46 0.00 0 1.84 0.00 0 1.62 0.00 0 1.97 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 71.55 54.41 35.49 30.61 25.10 16.36 25.09 17.96 32.67 115.48 133.04 Net Sales Growth 22.81% 53.31% 15.94% 21.95% 53.42% -34.79% 39.70% -45.03% -71.71% -13.20% Cost Of Goods Sold 41.33 28.48 18.56 12.31 14.81 9.07 15.07 25.38 28.16 112.60 120.32 Gross Profit 30.22 25.93 16.93 18.31 10.30 7.29 10.02 -7.43 4.51 2.89 12.72 GP Margin 42.23% 47.66% 47.70% 59.82% 41.04% 44.56% 39.94% -41.37% 13.80% 2.50% 9.56% Total Expenditure 60.89 46.40 30.24 26.36 22.96 16.91 26.85 70.19 55.94 121.00 127.72 Power & Fuel Cost - 1.14 1.10 0.98 0.78 0.58 0.73 1.08 0.98 1.05 0.81 % Of Sales - 2.10% 3.10% 3.20% 3.11% 3.55% 2.91% 6.01% 3.00% 0.91% 0.61% Employee Cost - 3.74 2.91 2.73 2.13 2.25 2.37 2.96 2.77 2.60 2.73 % Of Sales - 6.87% 8.20% 8.92% 8.49% 13.75% 9.45% 16.48% 8.48% 2.25% 2.05% Manufacturing Exp. - 3.34 2.17 1.91 1.02 0.69 0.70 0.94 1.06 0.79 0.65 % Of Sales - 6.14% 6.11% 6.24% 4.06% 4.22% 2.79% 5.23% 3.24% 0.68% 0.49% General & Admin Exp. - 4.50 2.84 3.62 1.26 1.74 1.59 1.65 2.71 1.83 1.21 % Of Sales - 8.27% 8.00% 11.83% 5.02% 10.64% 6.34% 9.19% 8.30% 1.58% 0.91% Selling & Distn. Exp. - 4.96 2.64 3.68 1.71 0.87 1.18 1.29 2.10 2.13 2.00 % Of Sales - 9.12% 7.44% 12.02% 6.81% 5.32% 4.70% 7.18% 6.43% 1.84% 1.50% Miscellaneous Exp. - 0.24 0.01 1.14 1.25 1.70 5.20 36.87 18.15 0.00 2.00 % Of Sales - 0.44% 0.03% 3.72% 4.98% 10.39% 20.73% 205.29% 55.56% 0% 0% EBITDA 10.67 8.01 5.25 4.25 2.14 -0.55 -1.76 -52.23 -23.27 -5.52 5.32 EBITDA Margin 14.91% 14.72% 14.79% 13.88% 8.53% -3.36% -7.01% -290.81% -71.23% -4.78% 4.00% Other Income 1.17 0.74 0.94 1.72 0.26 0.47 0.96 0.49 2.85 0.73 1.48 Interest 0.79 0.25 0.36 0.21 0.13 0.66 0.33 0.45 4.79 8.81 7.92 Depreciation 0.65 0.93 0.89 0.88 0.86 1.07 1.17 1.19 1.20 1.36 1.41 PBT 10.39 7.57 4.94 4.88 1.41 -1.81 -2.30 -53.37 -26.41 -14.96 -2.54 Tax 2.27 1.41 0.43 0.03 -0.01 -0.10 -0.23 -0.32 -0.19 -0.32 -0.36 Tax Rate 21.85% 18.63% 8.70% 0.61% -0.71% 5.52% 10.00% 0.60% 0.72% 2.14% 12.95% PAT 8.12 6.17 4.51 4.85 1.42 -1.71 -2.07 -53.06 -26.22 -14.64 -2.41 PAT before Minority Interest 8.12 6.17 4.51 4.85 1.42 -1.71 -2.07 -53.06 -26.22 -14.64 -2.41 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.35% 11.34% 12.71% 15.84% 5.66% -10.45% -8.25% -295.43% -80.26% -12.68% -1.81% PAT Growth 28.28% 36.81% -7.01% 241.55% - - - - - - EPS 6.82 5.18 3.79 4.08 1.19 -1.44 -1.74 -44.59 -22.03 -12.30 -2.03

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 27.90 -3.07 -7.58 -44.89 -48.91 -47.20 -52.82 -8.72 17.50 32.14 Share Capital 11.68 10.00 10.00 8.50 5.90 5.90 5.90 5.90 5.90 5.90 Total Reserves 14.19 -13.07 -17.58 -53.39 -54.81 -53.10 -58.72 -14.62 11.60 26.24 Non-Current Liabilities 1.73 1.43 3.99 6.54 9.18 9.50 6.02 8.50 14.12 6.87 Secured Loans 0.00 0.00 0.00 3.75 3.75 4.82 0.00 0.85 3.13 0.40 Unsecured Loans 0.97 0.76 2.75 1.56 4.21 3.31 4.46 6.12 9.26 4.39 Long Term Provisions 0.40 0.36 0.32 0.36 0.33 0.39 0.34 0.00 0.00 0.00 Current Liabilities 13.78 22.65 21.89 57.63 55.40 55.67 71.83 60.54 61.50 74.67 Trade Payables 5.74 13.72 11.44 10.59 10.79 12.09 11.76 3.28 6.02 12.36 Other Current Liabilities 7.02 8.16 9.74 9.68 7.21 6.17 18.63 6.26 6.05 11.60 Short Term Borrowings 0.00 0.00 0.00 36.60 36.60 36.60 40.57 50.33 48.70 49.95 Short Term Provisions 1.02 0.77 0.71 0.76 0.79 0.81 0.87 0.66 0.73 0.75 Total Liabilities 43.41 21.01 18.30 19.28 15.67 17.97 25.03 60.32 93.12 113.68 Net Block 9.94 7.57 7.42 7.62 8.04 8.99 10.17 11.19 12.69 13.52 Gross Block 27.03 23.73 22.80 22.11 21.68 21.55 21.87 21.84 22.14 21.62 Accumulated Depreciation 17.09 16.16 15.38 14.50 13.64 12.57 11.70 10.65 9.45 8.09 Non Current Assets 14.77 12.74 10.57 10.09 11.87 11.19 16.39 17.30 22.99 15.89 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Non Current Investment 0.00 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Long Term Loans & Adv. 4.81 5.11 3.10 2.38 3.72 2.10 6.17 6.06 9.14 0.75 Other Non Current Assets 0.01 0.01 0.00 0.05 0.05 0.05 0.00 0.00 1.12 1.56 Current Assets 28.64 8.27 7.73 9.18 3.79 6.78 8.63 43.02 70.12 97.79 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 9.73 5.35 1.75 0.91 1.66 0.56 2.37 9.83 20.16 22.61 Sundry Debtors 4.70 1.99 4.92 6.63 1.07 5.21 5.30 31.94 47.89 67.15 Cash & Bank 9.56 0.30 0.34 0.17 0.27 0.23 0.03 0.00 0.18 0.75 Other Current Assets 4.64 0.06 0.11 0.11 0.79 0.78 0.92 1.25 1.88 7.28 Short Term Loans & Adv. 4.61 0.57 0.61 1.35 0.70 0.73 0.89 1.14 1.39 6.14 Net Current Assets 14.86 -14.39 -14.17 -48.44 -51.61 -48.89 -63.20 -17.52 8.63 23.12 Total Assets 43.41 21.01 18.30 19.27 15.66 17.97 25.02 60.32 93.11 113.68

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -10.70 4.68 8.52 0.58 -0.17 2.48 3.05 9.57 0.45 -1.20 PBT 7.57 4.94 4.88 1.41 -1.81 -2.30 -53.37 -17.46 -14.96 -2.78 Adjustment 0.77 0.68 -0.52 1.36 1.56 1.32 1.54 5.81 9.46 8.26 Changes in Working Capital -17.93 -0.90 4.22 -2.16 0.08 3.49 54.89 21.21 5.97 -6.68 Cash after chg. in Working capital -9.59 4.72 8.57 0.62 -0.16 2.51 3.05 9.57 0.47 -1.20 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.11 -0.04 -0.05 -0.03 -0.01 -0.03 0.00 0.00 -0.02 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.21 -0.99 -0.67 -0.42 -0.12 0.02 -0.20 0.30 -0.50 8.68 Net Fixed Assets -3.30 -0.93 -0.69 -0.43 -0.13 0.32 -0.03 0.30 -0.51 11.96 Net Investments 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -8.96 -0.06 0.02 0.01 0.01 -0.30 -0.17 0.00 0.01 -3.28 Cash from Financing Activity 23.16 -3.73 -7.68 -0.26 0.33 -2.30 -2.83 -10.05 -0.51 -7.30 Net Cash Inflow / Outflow 0.24 -0.04 0.17 -0.09 0.03 0.20 0.03 -0.18 -0.57 0.18 Opening Cash & Equivalents 0.30 0.34 0.17 0.27 0.23 0.03 0.00 0.18 0.75 0.57 Closing Cash & Equivalent 0.54 0.30 0.34 0.17 0.27 0.23 0.03 0.00 0.18 0.75

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 22.14 -3.07 -7.58 -52.83 -82.93 -80.03 -89.55 -14.78 29.67 54.50 ROA 19.14% 22.96% 25.80% 8.13% -10.16% -9.62% -124.34% -34.18% -14.16% -2.09% ROE 54.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -596.93% -58.98% -7.19% ROCE 55.32% 0.00% 0.00% 266.43% -265.98% 0.00% -227.28% -33.04% -7.28% 5.69% Fixed Asset Turnover 2.25 1.53 1.39 1.17 0.76 1.16 0.82 1.49 5.28 4.83 Receivable days 21.40 35.41 67.67 54.78 69.98 76.45 378.42 445.93 181.80 181.07 Inventory Days 48.27 36.35 15.59 18.34 24.84 21.36 124.05 167.56 67.59 59.66 Payable days 124.71 247.38 326.74 263.55 460.61 202.97 82.07 46.16 27.95 43.95 Cash Conversion Cycle -55.03 -175.62 -243.48 -190.42 -365.80 -105.16 420.40 567.33 221.44 196.77 Total Debt/Equity 0.04 -0.81 -0.79 -1.03 -1.00 -1.02 -0.91 -6.87 3.55 1.78 Interest Cover 30.86 14.78 23.88 12.21 -1.76 -5.99 -118.94 -4.51 -0.70 0.65

Top Investors:

suresh pukhraj jain .

kanta suresh jain .

india equity fund 1

sun capital advisory services private limited

ashish kacholia

usha ravindra bhat

next orbit ventures fund

Annual Reports:

News Update:

Sanjivani Paranteral’s arm starts commercial production at IV Fluid infusion plant in Pune
8th Sep 2025, 15:38 PM

The facility has been designed with a dual focus on efficiency and sustainability
Read More
Sanjivani Paranteral - Quarterly Results
12th Aug 2025, 16:10 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback